View in EDS

Managing Cancer and Living Meaningfully (CALM) for Patients With Metastatic Cancer and Treatment Response.

Saved in:
Bibliographic Details
Title: Managing Cancer and Living Meaningfully (CALM) for Patients With Metastatic Cancer and Treatment Response.
Authors: de Vries, Froukje E. (AUTHOR), Hafkamp, Emma (AUTHOR), Huisman, Anne (AUTHOR), Kamps, Sanne (AUTHOR), Egeler, Mees (AUTHOR), Hales, Sarah (AUTHOR), Rodin, Gary (AUTHOR), van de Poll‐Franse, Lonneke (AUTHOR), Kool, Marianne (AUTHOR)
Source: Psycho-Oncology. Apr2026, Vol. 35 Issue 4, p1-11. 11p.
Subjects: Psychotherapy, Treatment effectiveness, Metastasis, Mortality, Social support, Patients' attitudes
Abstract: Background: Immunotherapy and targeted therapy can yield durable responses in metastatic cancer but introduce prognostic uncertainty and distress resembling that of patients with a limited life expectancy. Managing Cancer and Living Meaningfully (CALM) is a brief, flexible psychotherapy designed for advanced–stage patients and may also benefit treatment responders. Aims: To qualitatively assess how patients with metastatic lung cancer or melanoma experience life after responding to immunotherapy or targeted therapy, and to capture their perspectives on receiving CALM psychotherapy. Methods: Twenty‐two patients with metastatic lung cancer or melanoma and a confirmed therapy response began CALM as part of a larger study in the Netherlands. One year later, 20 were alive; 17 agreed to a semi‐structured interview. Two researchers independently conducted thematic analysis of the transcripts. Results: Four themes described becoming a responder: a twilight zone between health and illness, living in ongoing uncertainty, struggling to adapt, and a shift over time. Five themes emerged on CALM: a safe place to process cancer, resolving relational strain, navigating illness, being seen as a whole person, and an invitation to discuss mortality. Most participants found CALM helpful. They valued the invitation to address mortality, but felt ambivalent, acknowledging its importance yet lacking urgency unless progression loomed. Conclusions: Treatment responders face a shifting identity and enduring uncertainty as they adjust to life after a response. CALM can offer a support framework for those who struggle to establish a new equilibrium. Nonetheless, addressing mortality remains challenging when the timing of disease progression is unpredictable. [ABSTRACT FROM AUTHOR]
Copyright of Psycho-Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:Background: Immunotherapy and targeted therapy can yield durable responses in metastatic cancer but introduce prognostic uncertainty and distress resembling that of patients with a limited life expectancy. Managing Cancer and Living Meaningfully (CALM) is a brief, flexible psychotherapy designed for advanced–stage patients and may also benefit treatment responders. Aims: To qualitatively assess how patients with metastatic lung cancer or melanoma experience life after responding to immunotherapy or targeted therapy, and to capture their perspectives on receiving CALM psychotherapy. Methods: Twenty‐two patients with metastatic lung cancer or melanoma and a confirmed therapy response began CALM as part of a larger study in the Netherlands. One year later, 20 were alive; 17 agreed to a semi‐structured interview. Two researchers independently conducted thematic analysis of the transcripts. Results: Four themes described becoming a responder: a twilight zone between health and illness, living in ongoing uncertainty, struggling to adapt, and a shift over time. Five themes emerged on CALM: a safe place to process cancer, resolving relational strain, navigating illness, being seen as a whole person, and an invitation to discuss mortality. Most participants found CALM helpful. They valued the invitation to address mortality, but felt ambivalent, acknowledging its importance yet lacking urgency unless progression loomed. Conclusions: Treatment responders face a shifting identity and enduring uncertainty as they adjust to life after a response. CALM can offer a support framework for those who struggle to establish a new equilibrium. Nonetheless, addressing mortality remains challenging when the timing of disease progression is unpredictable. [ABSTRACT FROM AUTHOR]
ISSN:10579249
DOI:10.1002/pon.70450